Bio-Path Holdings News

Bio-Path Holdings Inc (BPTH) Q1 2024 Earnings Call Transcript Highlights: Strategic Advances ...

Yahoo FinanceMay 16 03:02 ET

Q1 2024 Bio Path Holdings Inc Earnings Call

Yahoo FinanceMay 16 00:12 ET

Earnings Call Summary | Bio-Path Holdings(BPTH.US) Q1 2024 Earnings Conference

The following is a summary of the Bio-Path Holdings Inc. (BPTH) Q1 2024 Earnings Call Transcript:Financial Performance:Bio-Path Holdings reported a net loss of $3.2 million or $4.88 per share for Q1 2

moomoo AIMay 15 11:35 ET · Conference Call

Bio-Path Holdings Inc. (BPTH) Q1 2024 Earnings Call Transcript

Bio-Path Holdings Inc. (BPTH) Q1 2024 Earnings Call Transcript

Earnings Call TranscriptsMay 15 11:04 ET

Bio-Path Holdings 1Q Loss/Shr $4.88 >BPTH

Bio-Path Holdings 1Q Loss/Shr $4.88 >BPTH

Dow JonesMay 15 07:02 ET

Express News | Bio-Path Q1 Net Income USD -3.2 Million

ReutersMay 15 07:00 ET

Press Release: Bio-Path Holdings Reports First Quarter 2024 Financial Results

Bio-Path Holdings Reports First Quarter 2024 Financial Results Marks Progress Across Key Clinical and Corporate Goals Strengthened Balance Sheet with $3.5 Million Conference Call to be Held Today a

Dow JonesMay 15 07:00 ET

Express News | Bio-Path Holdings Q1 2024 GAAP EPS $(4.88) Misses $(4.54) Estimate

BenzingaMay 15 06:06 ET

Bio-Path Holdings | 10-Q: Quarterly report

SEC announcementMay 14 16:17 ET · Announcements

Bio-Path Holdings to Announce First Quarter 2024 Financial Results on May 15, 2024

HOUSTON, May 08, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH) a biotechnology company leveraging its proprietary DNAbilize antisense RNAi nanoparticle technology to develop a po

GlobeNewswireMay 8 07:00 ET

Express News | Bio-Path Holdings Has Been Granted Israeli Patent Number 269608 Titled "COMPOSITIONS COMPRISING P-ETHOXY NUCLEIC ACIDS FOR STAT3 INHIBITION FOR USE IN TREATING CANCER OR AUTOIMMUNE DISEASE"

BenzingaMay 3 11:44 ET

Looking Into Bio-Path Hldgs's Recent Short Interest

Bio-Path Hldgs's (NYSE:BPTH) short percent of float has fallen 4.27% since its last report. The company recently reported that it has 67 thousand shares sold short, which is 8.96% of all regular share

BenzingaMay 1 14:00 ET

Bio-Path Holdings, Sunshine Biopharma, INVO Bioscience Among Healthcare Movers

Seeking AlphaApr 23 10:00 ET

Why Vaxxinity Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Shares of Vaxxinity, Inc. (NASDAQ:VAXX) fell sharply during Monday's session after the company announced its intention to voluntarily delist and deregister its Class A common stock.

BenzingaApr 22 13:26 ET

MRIN, WISA and SMFL Among Mid-day Movers

Seeking AlphaApr 22 12:52 ET

12 Health Care Stocks Moving In Monday's Intraday Session

GainersNKGen Biotech (NASDAQ:NKGN) shares rose 33.8% to $1.48 during Monday's regular session. The company's market cap stands at $33.7 million. The company's, Q4 earnings came out 4 days ago. MSP Rec

BenzingaApr 22 12:31 ET

Lexicon Pharmaceuticals, Bio-Path Holdings, Protara Therapeutics Among Healthcare Movers

Seeking AlphaApr 22 10:01 ET

Express News | Bio-Path Holdings, Inc. Announces Closing of $1.2 Million Registered Direct Offering Priced at-the-Market Under Nasdaq Rules

Moomoo 24/7Apr 19 12:14 ET

Why Wang & Lee Group Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket

Shares of Wang & Lee Group, Inc. (NASDAQ:WLGS) rose sharply in today's pre-market trading after the company reported a year-over-year increase in FY23 financial results.Wang & Lee Group posted a FY23

BenzingaApr 19 05:45 ET

12 Health Care Stocks Moving In Thursday's After-Market Session

GainersBio-Path Hldgs (NASDAQ:BPTH) stock moved upwards by 9.0% to $4.58 during Thursday's after-market session. The company's market cap stands at $3.4 million. Biora Therapeutics (NASDAQ:BIOR) share

BenzingaApr 18 16:31 ET